4.4 Article

Identification of an Oxidative Stress-Related LncRNA Signature for Predicting Prognosis and Chemotherapy in Patients With Hepatocellular Carcinoma

Journal

PATHOLOGY & ONCOLOGY RESEARCH
Volume 28, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/pore.2022.1610670

Keywords

hepatocellular carcinoma; survival analysis; immune cell infiltration; oxidative stress; drug sensitivity; lncRNA signature

Funding

  1. National Natural Science Foundation of China [81703527]

Ask authors/readers for more resources

This study explores the prognostic role of oxidative stress-related long non-coding RNAs (lncRNAs) in hepatocellular carcinoma (HCC). By analyzing gene expression data from The Cancer Genome Atlas (TCGA) database, a four-DElncRNA signature was constructed and shown to be a robust independent prognostic factor for overall survival. The signature was also found to regulate HCC progression and chemotherapeutic response, and was associated with immune cell infiltration. HCC patients in the high-risk group were more sensitive to conventional chemotherapeutic drugs. This study deepens our understanding of DElncRNA in HCC and provides a theoretical foundation for chemotherapy selection.
Background: Oxidative stress plays a critical role in oncogenesis and tumor progression. However, the prognostic role of oxidative stress-related lncRNA in hepatocellular carcinomas (HCC) has not been fully explored.Methods: We used the gene expression data and clinical data from The Cancer Genome Atlas (TCGA) database to identify oxidative stress-related differentially expressed lncRNAs (DElncRNAs) by pearson correlation analysis. A four-oxidative stress-related DElncRNA signature was constructed by LASSO regression and Cox regression analyses. The predictive signature was further validated by Kaplan-Meier (K-M) survival analysis, receiver operating characteristic (ROC) curves, nomogram and calibration plots, and principal component analysis (PCA). Single-sample gene set enrichment analysis (ssGSEA) was used to explore the relationship between the signature and immune status. Finally, the correlation between the signature and chemotherapeutic response of HCC patients was analyzed.Results: In our study, the four-DElncRNA signature was not only proved to be a robust independent prognostic factor for overall survival (OS) prediction, but also played a crucial role in the regulation of progression and chemotherapeutic response of HCC. ssGSEA showed that the signature was correlated with the infiltration level of immune cells. HCC patients in high-risk group were more sensitive to the conventional chemotherapeutic drugs including Sorafenib, lapatinib, Nilotinib, Gefitinib, Erlotinib and Dasatinib, which pave the way for targeting DElncRNA-associated treatments for HCC patients.Conclusion: Our study has originated a prognostic signature for HCC based on oxidative stress-related DElncRNAs, deepened the understanding of the biological role of four key DElncRNAs in HCC and laid a theoretical foundation for the choice of chemotherapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available